Total Payments
$950,053
2024 Payments
$131,875
Companies
79
Transactions
2,419
Medicare Patients
1,060
Medicare Billing
$104,162
Payment Breakdown by Category
Other$680,592 (71.6%)
Travel$105,951 (11.2%)
Consulting$90,547 (9.5%)
Food & Beverage$71,055 (7.5%)
Education$1,883 (0.2%)
Research$25.11 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $637,001 | 240 | 67.0% |
| Travel and Lodging | $105,951 | 405 | 11.2% |
| Consulting Fee | $90,547 | 27 | 9.5% |
| Food and Beverage | $71,055 | 1,715 | 7.5% |
| Honoraria | $43,591 | 18 | 4.6% |
| Education | $1,883 | 13 | 0.2% |
| Unspecified | $25.11 | 1 | 0.0% |
Payments by Type
General
$950,028
2,418 transactions
Research
$25.11
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $291,140 | 362 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $167,365 | 279 | $0 (2024) |
| MDD US Operations, LLC | $143,450 | 145 | $0 (2024) |
| US WorldMeds, LLC | $103,935 | 252 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $80,967 | 152 | $0 (2024) |
| Acorda Therapeutics, Inc | $54,198 | 93 | $0 (2024) |
| Adamas Pharmaceuticals, Inc. | $30,215 | 34 | $0 (2021) |
| Medtronic USA, Inc. | $14,682 | 316 | $0 (2020) |
| Impax Laboratories, Inc. | $8,170 | 18 | $0 (2018) |
| Medtronic, Inc. | $8,086 | 134 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $131,875 | 302 | Neurocrine Biosciences, Inc. ($64,254) |
| 2023 | $178,111 | 259 | Neurocrine Biosciences, Inc. ($106,186) |
| 2022 | $122,108 | 287 | Neurocrine Biosciences, Inc. ($64,692) |
| 2021 | $105,800 | 255 | MDD US Operations, LLC ($37,824) |
| 2020 | $51,370 | 230 | US WorldMeds, LLC ($22,272) |
| 2019 | $103,179 | 391 | Acorda Therapeutics, Inc ($26,926) |
| 2018 | $146,153 | 377 | ACADIA Pharmaceuticals Inc ($51,676) |
| 2017 | $111,456 | 318 | ACADIA Pharmaceuticals Inc ($58,108) |
All Payment Transactions
2,419 individual payment records from CMS Open Payments — Page 1 of 97
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $43.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Neuropsychiatry | ||||||
| 12/16/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 12/13/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/13/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $36.95 | General |
| Category: Central Nervous System | ||||||
| 12/11/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $26.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Honoraria | Cash or cash equivalent | $3,961.00 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Neurology | ||||||
| 12/02/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $23.27 | General |
| 12/02/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: AMANTADINE | ||||||
| 11/27/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Neurology | ||||||
| 11/26/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $41.97 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | Boston Scientific Corporation | Vercise (Device) | Food and Beverage | In-kind items and services | $48.45 | General |
| Category: Vercise_NMD | ||||||
| 11/20/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $179.98 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/20/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $176.64 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/16/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $74.48 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/16/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $7.04 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/15/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $36.98 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/15/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Travel and Lodging | In-kind items and services | $23.97 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/14/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: NEUROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| EFFECT OF LY3154207 ON COGNITION IN MILD TO MODERATE PARKINSONS DISEASE DEMENTIA PDD - THE PRESENCE STUDY | Eli Lilly and Company | $25.11 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 362 | 378 | $136,225 | $40,602 |
| 2022 | 5 | 167 | 221 | $43,897 | $12,346 |
| 2021 | 7 | 337 | 444 | $89,760 | $33,175 |
| 2020 | 5 | 194 | 275 | $58,996 | $18,039 |
Total Patients
1,060
Total Services
1,318
Medicare Billing
$104,162
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 165 | 165 | $68,958 | $20,228 | 29.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 75 | 78 | $28,844 | $8,860 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 62 | $17,719 | $5,470 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 59 | $13,285 | $4,028 | 30.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $7,419 | $2,015 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 121 | $22,627 | $6,395 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $12,209 | $3,164 | 25.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 14 | $2,030 | $1,011 | 49.8% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2022 | 20 | 28 | $3,696 | $908.33 | 24.6% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2022 | 11 | 29 | $3,335 | $867.41 | 26.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 117 | 187 | $34,969 | $12,900 | 36.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 73 | 73 | $30,733 | $9,781 | 31.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 59 | 73 | $10,585 | $5,874 | 55.5% |
| 95983 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, first 15 minutes face-to-face time with qualified health care professional | Office | 2021 | 26 | 48 | $6,336 | $1,801 | 28.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 17 | $4,837 | $1,706 | 35.3% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 23 | 24 | $1,200 | $732.96 | 61.1% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 22 | 22 | $1,100 | $379.50 | 34.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 78 | 132 | $24,684 | $6,469 | 26.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 45 | 45 | $18,945 | $5,461 | 28.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 38 | 43 | $6,235 | $3,634 | 58.3% |
| 95983 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, first 15 minutes face-to-face time with qualified health care professional | Office | 2020 | 20 | 42 | $5,544 | $1,546 | 27.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 13 | $3,588 | $929.27 | 25.9% |
About Dr. Eric Farbman, M.D
Dr. Eric Farbman, M.D is a Neurology healthcare provider based in Fresno, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912965773.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Farbman, M.D has received a total of $950,053 in payments from pharmaceutical and medical device companies, with $131,875 received in 2024. These payments were reported across 2,419 transactions from 79 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($637,001).
As a Medicare-enrolled provider, Farbman has provided services to 1,060 Medicare beneficiaries, totaling 1,318 services with total Medicare billing of $104,162. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Fresno, CA
- Active Since 05/02/2006
- Last Updated 09/23/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1912965773
Products in Payments
- INGREZZA (Drug) $273,414
- NUPLAZID (Drug) $167,365
- APOKYN (Drug) $115,215
- GOCOVRI (Drug) $99,069
- AUSTEDO (Drug) $65,473
- INBRIJA (Drug) $52,736
- Xadago (Drug) $31,269
- ACTIVA (Device) $14,498
- Gocovri (Drug) $13,266
- Ongentys (Drug) $10,345
- ONGENTYS (Drug) $10,343
- RYTARY (Drug) $8,355
- Austedo XR (Drug) $8,255
- MYOBLOC (Biological) $7,592
- KYNMOBI (Drug) $6,450
- SD809-HD (Drug) $4,553
- PERCEPT PC BRAINSENSE (Device) $4,413
- Apokyn (Drug) $4,291
- VERCISE (Device) $3,876
- INFINITY (Device) $3,509
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fresno
Dr. Melvin Helm, M.d, M.D
Neurology — Payments: $391,779
Neurology $391,779
Dr. Perminder Bhatia, Md, MD
Neurology — Payments: $290,555
Neurology $290,555
Nighat Sarwar, M.d, M.D
Neurology — Payments: $191,325
Neurology $191,325
Cong Zhi Zhao, M.d, M.D
Neurology — Payments: $116,400
Neurology $116,400
Amir Khan, Md, MD
Neurology — Payments: $63,489
Neurology $63,489
Dr. Abbas Mehdi, M.d, M.D
Neurology — Payments: $45,578
Neurology $45,578